Kaley Wilson
Chief Executive Officer at Sitka Biopharma, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brett H. Baker | M | - |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | - |
| Karimah Es Sabar | F | 66 |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada.
Quark Venture, Inc.
 Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | 8 years |
| Michael Parr | M | - |
Sitka Biopharma, Inc.
 Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | - |
| Jesson Chen | M | - |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | 9 years |
| Karim F. Lalji | M | - |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | - |
| John van de Pol | M | - |
Crohn?s & Colitis Canada
| - |
| Sonu Dhanju-Dhillon | F | - |
Crohn?s & Colitis Canada
| - |
| Lori Radke | F | - |
Crohn?s & Colitis Canada
| 3 years |
| Robert Gillam | M | - |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | 3 years |
| Leo Lianyi Han | M | - |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | - |
| Ruth Scully | F | - |
Crohn?s & Colitis Canada
| 20 years |
| Eric Benchimol | M | - |
Crohn?s & Colitis Canada
| - |
| Sylvain Chiasson | M | - |
Crohn?s & Colitis Canada
| - |
| Susan Cowan | F | - |
Crohn?s & Colitis Canada
| - |
| Ron Dunn | M | - |
Crohn?s & Colitis Canada
| - |
| Kathryn Hayashi | F | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | 6 years |
| Xiao Yu | M | - |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | 7 years |
| Zafrira Avnur | F | - |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | 8 years |
| Len Ducker | M | - |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | 5 years |
| Jason J. Harmon | M | - |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | 16 years |
| Zafrira Avnur | M | 73 |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | 8 years |
| Ken Harris | M | - |
Crohn?s & Colitis Canada
| - |
| Adrianna Czornyj | F | - |
Crohn?s & Colitis Canada
| - |
| Kristine Swiderek | M | - |
Sitka Biopharma, Inc.
Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sitka Biopharma, Inc. develops novel polymer platform technology that improves drug absorption for cancer treatments. The company was founded by Michael Parr in 2013 and is headquartered in Vancouver, the United Kingdom. | 7 years |
| Steve Thompson | M | - |
Crohn?s & Colitis Canada
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Charles S. Conroy | M | 54 |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 22 | 84.62% |
| United States | 4 | 15.38% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kaley Wilson
- Personal Network
